Intracerebral and Intrathecal Infusion of the TGF-β2-Specific Antisense Phosphorothioate Oligonucleotide AP 12009 in Rabbits and Primates: Toxicology and Safety-Reference-Cited by-同舟云学术

Intracerebral and Intrathecal Infusion of the TGF-β2-Specific Antisense Phosphorothioate Oligonucleotide AP 12009 in Rabbits and Primates: Toxicology and Safety

Published:2005-06 Issue:2 Volume:15 Page:94-104
ISSN:1545-4576
Container-title:Oligonucleotides
language:en
Short-container-title:Oligonucleotides

Author:

Schlingensiepen Reimar¹,Goldbrunner Michael¹,Szyrach Mara N.I.¹,Stauder Gerhard¹,Jachimczak Piotr¹,Bogdahn Ulrich²,Schulmeyer Frank³,Hau Peter²,Schlingensiepen Karl-Hermann¹

Affiliation:

1. Antisense Pharma GmbH, 93053 Regensburg, Germany.

2. Klinik und Poliklinik für Neurologie der Universität Regensburg, 93053 Regensburg, Germany.

3. Neurochirurgie an der Lohengrin Therme, 95448 Bayreuth, Germany.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/oli.2005.15.94

Reference25 articles.

1. Distribution and stability of antisense phosphorothioate oligonucleotides in rodent brain following direct intraparenchymal controlled-rate infusion